Acta Biomaterialia,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 1, 2025
This
study
investigated
the
development
and
characterization
of
decellularized
extracellular
matrix
(dECM)
hydrogels
tailored
for
biofabrication
female
reproductive
tissues,
specifically
targeting
ovarian
cortex,
endometrium,
medulla,
oviduct
tissues.
We
aimed
to
evaluate
cytocompatibility,
biomechanical
properties,
overall
efficacy
these
dECMs
in
promoting
cell
viability,
proliferation,
morphology
using
bovine
model.
Bovine
species
provide
a
valuable
model
due
their
accessibility
from
slaughterhouse
offering
practical
alternative
human
samples,
which
are
often
limited
availability.
Additionally,
tissue
closely
mirrors
certain
physiological
biological
characteristics
humans,
making
it
relevant
translational
research.
Our
findings
revealed
that
exhibited
high
biocompatibility
with
embryo
supporting
micro
vascularization
cellular
without
need
external
growth
factors.
It
is
important
note
addition
alginate
was
crucial
maintaining
structural
integrity
hydrogel
during
long-term
cultures.
These
displayed
properties
mimicked
native
vital
functional
activities.
The
printability
assessments
showed
dECMs,
particularly
those
cortex
achieved
precision
replicating
intended
structures,
though
challenges
such
as
low
porosity
remained.
bioprinted
constructs
demonstrated
robust
growth,
over
97%
viability
observed
by
day
7,
indicating
suitability
culture.
work
represented
significant
advancement
biofabrication,
demonstrating
potential
dECM-based
creating
structurally
viable
constructs.
By
tailoring
each
dECM
match
unique
different
we
paved
way
more
effective
reliable
applications
medicine
engineering.
STATEMENT
OF
SIGNIFICANCE:
research
explores
use
bio-inks
Ovarian
endometrium
essential
processes.
Notably,
microvascularization
differentiation
supplemental
successful
bioprinting
underscores
complex
models.
represents
engineering,
promising
new
avenues
medicine.
Frontiers in Cardiovascular Medicine,
Journal Year:
2022,
Volume and Issue:
9
Published: March 4, 2022
Despite
the
efforts
devoted
to
drug
discovery
and
development,
number
of
new
approvals
have
been
decreasing.
Specifically,
cardiovascular
developments
showing
amongst
lowest
levels
approvals.
In
addition,
concerns
over
adverse
effects
drugs
system
increasing
resulting
in
failure
at
preclinical
level
as
well
withdrawal
post-marketing.
Besides
factors
such
increased
cost
clinical
trials
increases
requirements
complexity
regulatory
processes,
there
is
also
a
gap
between
currently
existing
pre-clinical
screening
methods
studies
humans.
This
mainly
caused
by
lack
used
2D
cell
culture-based
systems,
which
do
not
accurately
reflect
human
physiological
conditions.
Cell-based
widely
accepted
extensively
can
provide
an
initial
indication
drugs'
therapeutic
efficacy
potential
cytotoxicity.
However,
vitro
cell-based
evaluation
could
many
instances
contradictory
findings
vivo
testing
animal
models
trials.
drawback
related
these
culture
systems
recapitulate
microenvironment
cells
reside.
body,
reside
within
complex
setting,
where
they
interact
with
respond
neighboring
cells,
extracellular
matrix,
mechanical
stress,
blood
shear
other
factors.
These
sum
affect
cellular
response
specific
pathways
that
regulate
variable
vital
functions
proliferation,
apoptosis,
differentiation.
Although
this
complexity,
cross
species
differences
cause
results
from
seen
when
enters
Thus,
need
better
mimic
conditions
improve
efficiency
screening.
A
novel
approach
develop
3D
tissue
engineered
miniaturized
constructs
are
based
on
cells.
review,
we
discuss
should
be
considered
produce
successful
vascular
construct
derived
both
reliable
reproducible.
Artificial Organs,
Journal Year:
2022,
Volume and Issue:
46(7)
Published: March 29, 2022
Abstract
Background
Tissue
engineering
provides
various
strategies
to
fabricate
an
appropriate
microenvironment
support
the
repair
and
regeneration
of
lost
or
damaged
tissues.
In
this
matter,
several
technologies
have
been
implemented
construct
close‐to‐native
three‐dimensional
structures
at
numerous
physiological
scales,
which
are
essential
confer
functional
characteristics
living
Methods
article,
we
review
a
variety
microfabrication
that
currently
utilized
for
tissue
applications,
such
as
soft
lithography,
microneedles,
templated
self‐assembly
microstructures,
microfluidics,
fiber
spinning,
bioprinting.
Results
These
considerably
helped
us
precisely
manipulate
cells
cellular
constructs
fabrication
biomimetic
tissues
organs.
Although
available
still
lack
some
crucial
functionalities,
including
vascular
networks,
innervation,
lymphatic
system,
being
proposed
overcome
these
issues.
Moreover,
techniques
progressed
preclinical
stage
also
discussed.
Conclusions
This
article
aims
highlight
advantages
drawbacks
each
technique
areas
further
research
more
comprehensive
evolving
understanding
in
terms
regenerative
medicine
applications.
International Journal of Bioprinting,
Journal Year:
2023,
Volume and Issue:
9(3), P. 712 - 712
Published: March 16, 2023
Collagen
is
a
cornerstone
protein
for
tissue
engineering
and
3D
bioprinting
due
to
its
outstanding
biocompatibility,
low
immunogenicity,
natural
abundance
in
human
tissues.
Nonetheless,
it
still
poses
some
important
challenges,
such
as
complicated
limited
extraction
processes,
usually
accompanied
by
batch-
to-batch
reproducibility
influence
of
factors,
temperature,
pH,
ionic
strength.
In
this
work,
we
evaluated
the
suitability
performance
new,
fibrillar
type
I
collagen
standardized
reproducible
source
printing
bioprinting.
The
acidic,
native
fibrous
formulation
(5%
w/w)
performed
remarkably
during
printing,
which
was
possible
print
constructs
up
27
layers
without
collapsing.
On
other
hand,
mass
has
been
modified
provide
fast,
reliable,
easily
neutralizable
process.
neutralization
with
TRIS-HCl
enabled
inclusion
cells
hindering
printability.
cell-laden
were
printed
under
mild
conditions
(50-80
kPa,
pneumatic
printing),
providing
remarkable
cellular
viability
(>90%)
well
stable
platform
cell
growth
proliferation
vitro.
Therefore,
native,
masses
characterized
work
offer
reliable
purposes.
Bio-Design and Manufacturing,
Journal Year:
2024,
Volume and Issue:
7(2), P. 181 - 205
Published: March 1, 2024
Abstract
Three-dimensional
(3D)
printing
and
bioprinting
have
come
into
view
for
a
plannable
standardizable
generation
of
implantable
tissue-engineered
constructs
that
can
substitute
native
tissues
organs.
These
structures
are
intended
to
integrate
with
the
patient’s
body.
Vascular
tissue
engineering
(TE)
is
relevant
in
TE
because
it
supports
sustained
oxygenization
nutrition
all
constructs.
Bioinks
specific
role,
representing
necessary
medium
printability
vascular
cell
growth.
This
review
aims
understand
requirements
design
bioinks.
First,
an
in-depth
analysis
interaction
their
environment
must
be
gained.
A
physiological
bioink
suitable
graft
(TEVG)
not
only
ensure
good
but
also
induce
cells
behave
like
vessel,
including
self-regenerative
growth
functions.
describes
general
structure
walls
wall-specific
extracellular
matrix
(ECM)
components
biomechanical
properties
Furthermore,
role
ECM
mode
introduced.
Diverse
currently
available
or
imaginable
bioinks
described
from
proteins
nonphysiologically
occurring
natural
chemical
compounds
useful
bioprinting.
The
performance
these
evaluated
regard
postprinting,
current
animal
studies
3D
printed
structures.
Finally,
main
challenges
further
development,
create
self-assembly
concept,
future
strategies
outlined.
concepts
discussed
terms
suitability
part
TEVG
high
potential
later
clinical
use.
BioChip Journal,
Journal Year:
2024,
Volume and Issue:
18(3), P. 345 - 356
Published: May 14, 2024
Abstract
The
vascular
system,
essential
for
human
physiology,
is
vital
transporting
nutrients,
oxygen,
and
waste.
Since
structures
are
involved
in
various
disease
pathogeneses
exhibit
different
morphologies
depending
on
the
organ,
researchers
have
endeavored
to
develop
organ-specific
models.
While
animal
models
possess
sophisticated
morphologies,
they
significant
discrepancies
from
tissues
due
species
differences,
which
limits
their
applicability.
To
overcome
limitations
arising
these
oversimplification
of
2D
dish
cultures,
microphysiological
systems
(MPS)
emerged
as
a
promising
alternative.
These
more
accurately
mimic
microenvironment
by
incorporating
cell
interactions,
physical
stimuli,
extracellular
matrix
components,
thus
facilitating
enhanced
tissue
differentiation
functionality.
Importantly,
MPS
often
utilize
human-derived
cells,
greatly
reducing
disparities
between
model
patient
responses.
This
review
focuses
recent
advancements
MPS,
particularly
modeling
discusses
potential
biological
adaptation.
Pharmaceutics,
Journal Year:
2021,
Volume and Issue:
13(11), P. 1806 - 1806
Published: Oct. 28, 2021
The
adaptation
and
progress
of
3D
printing
technology
toward
bioprinting
(specifically
adapted
to
biomedical
purposes)
has
opened
the
door
a
world
new
opportunities
possibilities
in
tissue
engineering
regenerative
medicine.
In
this
regard,
allows
for
production
tailor-made
constructs
organs
as
well
custom
implants
medical
devices.
As
it
is
growing
field
study,
currently,
attention
heeded
on
optimization
improvement
mechanical
biological
properties
so-called
bioinks/biomaterial
inks.
One
strategies
proposed
use
inorganic
ingredients
(clays,
hydroxyapatite,
graphene,
carbon
nanotubes
other
silicate
nanoparticles).
Clays
have
proven
be
useful
rheological
reinforcement
wide
range
fields,
from
building
industry
pharmacy.
Moreover,
they
are
naturally
occurring
materials
with
recognized
biocompatibility
bioactivity,
revealing
them
optimal
candidates
cutting-edge
technology.
This
review
deals
clays
(both
natural
synthetic)
medicine
through
bioprinting.
Despite
limited
number
studies,
possible
conclude
that
play
fundamental
role
formulation
bioinks
biomaterial
inks
since
able
improve
their
rheology
properties,
thus
improving
printability
construct
resistance.
Additionally,
also
exceptionally
functional
(enhancing
cellular
proliferation,
adhesion,
differentiation
alignment),
controlling
biodegradation
carrying/releasing
actives
regeneration
therapeutic
activities.
Materials Today Bio,
Journal Year:
2023,
Volume and Issue:
23, P. 100846 - 100846
Published: Oct. 28, 2023
3D
bioprinting
technology
is
widely
used
to
fabricate
various
tissue
structures.
However,
the
absence
of
vessels
hampers
ability
bioprinted
tissues
receive
oxygen
and
nutrients
as
well
remove
wastes,
leading
a
significant
reduction
in
their
survival
rate.
Despite
advancements
bioinks
technologies,
vascular
structures
continue
be
unsuitable
for
transplantation
compared
natural
blood
vessels.
In
addition,
complete
assessment
index
system
evaluating
structure
function
vitro
has
not
yet
been
established.
Therefore,
this
review,
we
firstly
highlight
significance
selecting
suitable
techniques
they
two
synergize
with
each
other.
Subsequently,
focusing
on
both
vascular-associated
cells
tissues,
provide
relatively
thorough
functions
based
physiological
that
possess.
We
end
review
applications
models,
such
vessel-on-a-chip,
simulating
pathological
processes
conducting
drug
screening
at
organ
level.
believe
development
fully
functional
will
soon
make
great
contributions
engineering
regenerative
medicine.
Biomolecules,
Journal Year:
2023,
Volume and Issue:
13(8), P. 1180 - 1180
Published: July 28, 2023
Three-dimensional
(3D)
printing
plays
an
important
role
in
cardiovascular
disease
through
the
use
of
personalised
models
that
replicate
normal
anatomy
and
its
pathology
with
high
accuracy
reliability.
While
3D
printed
heart
vascular
have
been
shown
to
improve
medical
education,
preoperative
planning
simulation
cardiac
procedures,
as
well
enhance
communication
patients,
bioprinting
represents
a
potential
advancement
technology
by
allowing
cellular
or
biological
components,
functional
tissues
organs
can
be
used
variety
applications
disease.
Recent
advances
ability
support
vascularisation
large-scale
constructs
enhanced
biocompatibility
structural
stability,
thus
creating
opportunities
replace
damaged
organs.
In
this
review,
we
provide
overview
focus
on
technologies
tissues,
grafts,
valves
myocardium.
Limitations
future
research
directions
are
highlighted.
Advanced Healthcare Materials,
Journal Year:
2024,
Volume and Issue:
unknown
Published: May 15, 2024
Granular
hydrogels
composed
of
hydrogel
microparticles
are
promising
candidates
for
3D
bioprinting
due
to
their
ability
protect
encapsulated
cells.
However,
achieve
high
print
fidelity,
need
jam
exhibit
shear-thinning
characteristics,
which
is
crucial
printing.
Unfortunately,
this
overpacking
can
significantly
impact
cell
viability,
thereby
negating
the
primary
advantage
using
shield
cells
from
shear
forces.
To
overcome
challenge,
a
novel
solution:
biphasic,
granular
colloidal
bioink
designed
optimize
viability
and
printing
fidelity
introduced.
The
biphasic
ink
consists
cell-laden
polyethylene
glycol
(PEG)
embedded
in
continuous
gelatin
methacryloyl
(GelMA)-nanosilicate
network.
Here,
it
demonstrated
that
offers
outstanding
rheological
properties,
structural
stability.
Furthermore,
its
utility
engineering
complex
tissues
with
multiple
types
heterogeneous
microenvironments
demonstrated,
by
incorporating
β-islet
into
PEG
endothelial
GelMA-nanosilicate
Using
approach,
possible
induce
patterning,
enhance
vascularization,
direct
cellular
function.
proposed
holds
significant
potential
numerous
emerging
biomedical
applications,
including
tissue
disease
modeling.